Skip to content

Released Mar 8, 2018, after the close

10-K filed Mar 8, 2018, 67 days after period end · 0001162194-18-000032

Q4 2017 · 10-K
Revenue$27.75M+10.6% vs Q4 2016+12.1% vs Q3 2017
Net Income-$10.46MderivedN/M vs Q4 2016N/M vs Q3 2017
EPS Diluted-$0.27N/M vs Q4 2016N/M vs Q3 2017
Operating Incomederived-$8,735,000N/M
Operating Cash Flowderived$661,000N/M
Free Cash Flowderived$483,000N/M
Margins · derived
Operating margin-31.5%+39.1 pt vs Q4 2016
Net margin-37.7%+32.9 pt vs Q4 2016

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-K.

Same quarter

MetricQ4 2017Q4 2016Q4 2015Q4 2014
Revenue$27.75M$25.08M$30.72M$33.49M
Net Income-$10.46M-$17.70M-$12.88M-$10.94M
EPS Diluted-$0.27-$0.61-$0.45-$0.39

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Standard Biotools Inc. · CIK 1162194 · Engraved from SEC EDGAR